羟基茜草素对大鼠膝骨关节炎的软骨保护及抗炎作用研究

Chondroprotective and anti-inflammatory effect of purpurin on osteoarthritis of the knee in rats

  • 摘要: 目的:研究羟基茜草素对大鼠膝骨关节炎(OA)的软骨保护及抗炎作用。方法:体外提取SD大鼠的软骨细胞,随机分成对照组、模型组白介素-1β(IL-1β)处理和治疗组(IL-1β+羟基茜草素处理)。采用细胞计数试剂盒(CCK-8)评估羟基茜草素对软骨细胞的毒性作用。钙黄绿素(Calcein-AM)/碘化丙啶(PI)染色评估软骨细胞活力,活性氧(ROS)检测实验评估软骨细胞内ROS水平的变化情况。结合Swiss Target Prediction、SuperPred、Sea、GeneCards、OMIM数据库筛选羟基茜草素治疗OA的潜在作用靶点,用AutoDock Vina和Pymol软件对羟基茜草素与交集靶点进行分子对接。实时荧光定量PCR(RT-qPCR)检测软骨细胞炎症相关基因和特征性基因的相对表达量。将18只大鼠随机分成对照组、模型组和治疗组,模型组和治疗组用切断前交叉韧带的方法构建关节炎模型,建模4周后,每周向治疗组的大鼠关节腔注射100 μL的羟基茜草素溶液,对照组和模型组注射等体积的生理盐水。通过HE染色和番红O-固绿染色评估大鼠关节组织病理情况。结果:CCK-8结果表明,50 μmol/L的羟基茜草素对软骨细胞无毒性,且促其增殖(P< 0.001)。Calcein-AM/PI染色结果显示,治疗组的死细胞数量比模型组少,活细胞数量也有所增加(P< 0.01)。ROS含量检测结果显示,治疗组的荧光强度比模型组减弱(P< 0.05)。药物靶点筛选及分子对接结果表明,羟基茜草素可能通过调节转甲状腺素蛋白(TTR)、B淋巴细胞瘤-2(BCL2)和基质金属蛋白酶1(MMP1)的表达影响OA的进程。RT-qPCR结果显示,与模型组相比,治疗组的炎症基因相对表达量显著下降(P < 0.01),而治疗组的软骨特征性基因相对表达量有所增加(P < 0.001)。组织学染色结果显示,相比于炎症组,治疗组的软骨组织损伤有所减轻。结论:羟基茜草素对大鼠OA具有软骨保护作用,可减轻软骨细胞的炎症反应,可能是潜在的治疗关节炎药物。

     

    Abstract: Objective:To study the chondroprotective and anti-inflammatory effect of purpurin on osteoarthritis(OA)of the knee in rats.Methods:Chondrocytes from SD rats were extracted in vitro and randomly divided into control, model(IL-1β-treated)and treatment groups(IL-1β and purpurin-treated).The cell counting kit(CCK-8)was used to assess the toxic effect of purpurin on chondrocytes.Chondrocyte viability was assessed by Calcein-AM/Propidium iodide(PI)staining, and ROS levels of chondrocytes were assessed by reactive oxygen species detection assay.Based on Swiss Target Prediction, SuperPred, Sea, GeneCards and OMIM databases, the potential targets of purpurin for knee OA were screened, and molecular docking between purpurin and intersecting targets was performed using AutoDock Vina and Pymol softwares.The relative expressions of inflammation-related and characteristic genes in chondrocytes were mea-sured by real-time fluorescence quantitative polymerase chain reaction (RT-qPCR).Eighteen rats were randomly divided into control, model and treatment groups.Arthritis models were constructed by severing the anterior cruciate ligament in the model and treatment groups.After four weeks of modeling, 100 μL of purpurin solution was injected into the joint cavity of rats in the treatment group and an equal volume of saline in the control and model groups every week.The histopathological conditions of the rat joints were evaluated by HE staining and staining with senna O-fix green.Results:CCK-8 results showed that 50 μmol/L of purpurin was not toxic to chondrocytes and promoted their proliferation (P< 0.001).Calcein-AM/PI staining showed that the number of dead cells was less and the number of live cells also increased in the treatment group compared with the model group(P< 0.01).The results of the reactive oxygen content assay showed that the fluorescence intensity was diminished in the treatment group compared with the model group (P< 0.05).The results of drug target screening and molecular docking suggested that purpurin might affect the progression of OA by regulating the expressions of transthyretin(TTR), B lymphocytoma-2 (BCL2) and matrix metalloproteinase 1 (MMP1).RT-qPCR results showed that the relative expressions of inflammatory genes in the treated group compared with the model group significantly decreased (P< 0.01), while the relative expressions of cartilage-characteristic genes increased in the treatment group (P< 0.001).Histological staining results showed that cartilage tissue damage was reduced in the treatment group compared to the inflammation group.Conclusion:Purpurin has a chondroprotective effect on OA of the knee in rats and reduces the inflammatory response of chondrocytes.It may be a potential drug for the treatment of arthritis.

     

/

返回文章
返回